Literature DB >> 3489973

Circulating human leucocyte elastase in rheumatoid arthritis.

E O Adeyemi, R G Hull, V S Chadwick, G R Hughes, H J Hodgson.   

Abstract

Elastase-inhibitor complex (EIC) levels were determined in EDTA-plasma samples of 40 patients with connective tissue disease by a double antibody immuno-assay technique. In active rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), EIC levels were significantly higher than in the normal controls (P less than 10(-8) and fell on remission. The mean EIC level in active RA was significantly greater than in inactive disease (P = 0.0001) but there was no statistically significant difference between the EIC levels in the acute and inactive disease states in SLE (P = 0.49). In active RA, there was a positive correlation between EIC levels and white blood cell count (WBC) but not with erythrocyte sedimentation rate (ESR). In SLE there was no significant correlation between EIC levels and ESR or WBC. EIC measurement may be useful in the objective assessment of activity in RA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489973     DOI: 10.1007/BF00541505

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  30 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Circulating human leucocyte elastase in patients with inflammatory bowel disease.

Authors:  E O Adeyemi; S Neumann; V S Chadwick; H J Hodgson; M B Pepys
Journal:  Gut       Date:  1985-12       Impact factor: 23.059

3.  Leukocyte elastase and free collagenase activity in synovial effusions: relation to numbers of polymorphonuclear leukocytes.

Authors:  G Cohen; K Fehr; F J Wagenhäuser
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

Review 4.  Leukocyte elastase.

Authors:  A J Barrett
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

5.  Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. Characterization and effects on blood coagulation in vitro.

Authors:  M Gramse; C Bingenheimer; W Schmidt; R Egbring; K Havemann
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

6.  A radioassay for proteolytic cleavage of isolated cartilage proteoglycan. 2. Inhibition of human leukocyte elastase and cathepsin G by anti-inflammatory drugs.

Authors:  R W Stephens; E A Walton; P Ghosh; T K Taylor; M Gramse; K Havemann
Journal:  Arzneimittelforschung       Date:  1980

7.  Specific cleavage of human type III collagen by human polymorphonuclear leukocyte elastase.

Authors:  C L Mainardi; D L Hasty; J M Seyer; A H Kang
Journal:  J Biol Chem       Date:  1980-12-25       Impact factor: 5.157

8.  Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus.

Authors:  G J Becker; M Waldburger; G R Hughes; M B Pepys
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

9.  Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase.

Authors:  M S Brower; P C Harpel
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

10.  Alpha-1-antitrypsin-human leukocyte elastase complexes in blood: quantification by an enzyme-linked differential antibody immunosorbent assay and comparison with alpha-2-plasmin inhibitor-plasmin complexes.

Authors:  M S Brower; P C Harpel
Journal:  Blood       Date:  1983-05       Impact factor: 22.113

View more
  5 in total

1.  Cytidine deaminase activity in synovial fluid of patients with rheumatoid arthritis: relation to lactoferrin, acidosis, and cartilage proteoglycan release.

Authors:  B Månsson; P Geborek; T Saxne; S Björnsson
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

2.  Effect of piroxicam therapy on granulocyte function and granulocyte elastase concentration in peripheral blood and synovial fluid of rheumatoid arthritis patients.

Authors:  C Montecucco; A Mazzone; D Pasotti; R Caporali; M Longhi; D Casilli; G Ricevuti; P Fratino; M P Ruffilli
Journal:  Inflammation       Date:  1989-04       Impact factor: 4.092

3.  Plasma and synovial fluid levels of granulocytal elastase-alpha-1-protease inhibitor complex in patients with rheumatoid arthritis.

Authors:  K Kuramitsu; A Yoshida
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

4.  Role of granulocyte elastase in tissue injury in patients with septic shock complicated by multiple-organ failure.

Authors:  H Tanaka; H Sugimoto; T Yoshioka; T Sugimoto
Journal:  Ann Surg       Date:  1991-01       Impact factor: 12.969

5.  Circulating inhibitor bound elastase in patients with ankylosing spondylitis and rheumatoid arthritis and the influence of sulphasalazine treatment.

Authors:  N Feltelius; R Hällgren
Journal:  Ann Rheum Dis       Date:  1988-01       Impact factor: 19.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.